NanoSyrinx

Coventry, England, United Kingdom

https://www.nanosyrinx.com/

Company profile

NanoSyrinx company profile

NanoSyrinx is an emerging biotechnology company developing a novel system for targeted delivery of therapeutic proteins and peptides direct to the cytosol. We are using synthetic biology approaches to develop a completely novel method for targeted drug delivery of therapeutic proteins and peptides, to the interiors of cells, to improve efficacy, safety, and economy.

Business identity

Website: https://www.nanosyrinx.com/
Contact email: [email protected]
Operating status: Active
Company type: For Profit
Employee range: 00001-00010 employees
Revenue range: $1K+
Founded: 2018-01-01

LinkedIn X

Headquarters

Headquarters: Coventry, England, United Kingdom
Postal code: CV47EZ
Country code: GB
Continent: Europe

Capital profile

Funding and company signals

Funding stage: Early Stage Venture
Funding rounds: 3
Total equity funding: $21.6M
Last funding: Series A / $13.1M / 2024-09-10
Last equity funding: Series A / $13.1M
Investors: 10
Lead investors: 3
Founders: 1
Articles: 14

Categories and groups

Biotechnology Medical Therapeutics Biotechnology Health Care Science and Engineering

Founders and investors

Founders

Joseph Healey

Lead investors

Business Growth FundM VenturesOctopus Ventures

Investors

Business Growth FundEli LillyFuture Planet CapitalIQ CapitalOctopus Ventures

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.